Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Zeliha Başak Çakır Erdil clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Turkey register with Zeliha Başak Çakır Erdil as lead sponsor. Synced 8 Oct 2026
3Current trials
1Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Zeliha Başak Çakır Erdil is the lead sponsor of 3 current clinical trials in our Turkey register. 1 is recruiting patients now. The most common phase is Not applicable. The most-studied condition is Periodontal Diseases.

ClinicalTrials.gov trials by status

  • Recruiting133%
  • Not yet open133%
  • Active, closed133%

Trials by phase

  • Not applicable267%
  • Observational133%
01

Clinical trials sponsored by Zeliha Başak Çakır Erdil

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Root Coverage Performance of Restorative Materials in Class V Cavities
NCT07687654 · ClinicalTrials.gov ↗ · Gingival Recession, Non-Carious Cervical Lesions (NCCLs)
Not applicable Recruiting 2025-11 Turkey
Retinal and Choroidal Changes in Periodontal Disease
NCT07856901 · ClinicalTrials.gov ↗ · Periodontal Diseases, Periodontal Diseases Inflammation, Retinal Thickening
Observational Not yet open 2026-10 Turkey
Ozone Versus Conventional Socket Disinfection for Primary Dental Implant Stability
NCT07687680 · ClinicalTrials.gov ↗ · Dental Implant Placement, Ozone Therapy
Not applicable Active, closed 2025-11 Turkey

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Zeliha Başak Çakır Erdil trials

7 conditions
Periodontal Diseases1Periodontal Diseases Inflammation1Retinal Thickening1Dental Implant Placement1Ozone Therapy1Gingival Recession1Non-Carious Cervical Lesions (NCCLs)1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Turkey31

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Periodontal Diseases

SponsorTrials
Universidad de Murcia3
University of Pavia2
Istanbul Saglik Bilimleri University2
Kaohsiung Medical University Chung-Ho Memorial Hospital2
University of Guarulhos1

Sponsors with the most current trials registered for this condition.

05

Questions about Zeliha Başak Çakır Erdil trials

How many clinical trials does Zeliha Başak Çakır Erdil sponsor?

Zeliha Başak Çakır Erdil is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Turkey register, as of the registry sync on 8 October 2026. Completed and withdrawn studies are not counted.

Are Zeliha Başak Çakır Erdil trials recruiting?

Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 8 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.